Latest news
NRx Pharmaceuticals to Host Conference Call on FDA First-Cycle Review of Preservative-Free Ketamine ANDA - Quiver QuantitativeQuiver Quantitative · Fri, 07 Aug 2026 20:10:00 GMTNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Conference Call August 10 to Discuss FDA First-Cycle ANDA Review and Commercial Plans - The Manila TimesThe Manila Times · Fri, 07 Aug 2026 20:05:48 GMTFDA completes review of NRx Pharmaceuticals preservative-free ketamine ANDA - TipRanksTipRanks · Fri, 07 Aug 2026 19:39:14 GMTNRx Pharma rises on FDA review of ketamine ANDA (NRXP:NASDAQ) - Seeking AlphaSeeking Alpha · Fri, 07 Aug 2026 17:08:38 GMTFDA Clears Major Regulatory Hurdle as Preservative-Free Ketamine Program Moves Within Reach of Commercialization: NRx Pharmaceuticals: (NAS DAQ: NRXP) - PRLogPRLog · Fri, 07 Aug 2026 13:50:38 GMTNRx Advances FDA Review of Ketamine ANDA Packaging Issue - TipRanksTipRanks · Fri, 07 Aug 2026 13:08:21 GMTNRx says FDA restarts review of preservative-free ketamine ANDA after vial-cap concern flagged - BitgetBitget · Fri, 07 Aug 2026 11:31:15 GMTFDA Completes First-Cycle Review of Preservative-Free - GlobeNewswireGlobeNewswire · Fri, 07 Aug 2026 11:00:00 GMT